e-eso

5th ESO-ESMO-RCE Clinical update on RARE ADULT SOLID CANCERS

Programme

Chairs: J.Y. Blay, FR - P.G. Casali, IT - R. Stahel, CH

REMEMBER TO COMPLETE THE COURSE BEFORE JANUARY 2022!

The course is an ESO-ESMO-RCE joint event

In partnership with

In collaboration with

The “ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers” is an educational effort held on an annual basis and conceived to strengthen the education of medical professionals willing to devote their career to rare cancers.

Despite being rare as single entities, rare adult solid cancers account for as many as 15% of all new cancer cases, thus being the main group within rare cancers in general. The definition of rare cancers by the RARECARE project and the list of the 10 “families” of rare adult solid cancers gave rise to shape the sessions of this course:

- Head & neck cancers
- Sarcomas
- Rare thoracic tumors
- Neuroendocrine tumors
- Central nervous system neoplasms
- Rare female genital cancers
- Endocrine gland tumors
- Digestive rare cancers
- Rare urological and male genital tumors
- Rare skin cancers & non-cutaneous melanoma

Since ‘networking’ and ‘multidisciplinarity’ are the two main keywords to improve the quality of care of rare cancers, ESO has decided to develop the programme of this course in collaboration with other the European initiatives in this field and to give its contribution to tackle the rare cancer issue. The 5th ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers was conceived in the context of, and supported by, EURACAN, the European Reference Network on rare adult solid cancers. The Faculty has been largely selected from EURACAN, also with the aim of letting this educational effort closely interact with its networking activities.

Optimal management of rare adult solid cancers poses specific diagnostic and therapeutic challenges. The sessions of the course have been designed to address the needs of clinical oncologists wanting an update on recent advancements on these tumours.

The global health crisis caused by the Covid-19 pandemic has forced us to turn the in-person course into a virtual event. It is anyhow a good opportunity to receive updates on the available evidence in this field and promote future networking and collaborations.

We have done our best to design an online course enabling participants to attend according to their own schedule. There has been a mixture of pre-recorded sessions and live sessions for Q & A and clinical case discussions with faculty members and moderators.

Paolo Casali
On behalf of the co-Chairs

INFORMATION
The course will be carried out in two different steps:
Step 1
Pre-recorded sessions were made available from 1st December 2020 and will remain on the e-eso website until January 2022.
Step 2
Live sessions with an introductory round table on rare cancers in general, clinical case presentations and Q&A discussions with moderators and speakers was held on 16 and 17 January 2021.

During the Q&A sessions, speakers have answered and discussed a number of selected questions received in advance.

All the contents have been recorded and are accessible via the e-ESO website until January 2022 (registration to access the contents will remain open).

IDEAL PARTICIPANT'S PROFILE

- Medical degree

- Specialization/residency in medical oncology, radiation oncology, surgical oncology or equivalent

LEARNING OBJECTIVES

Provide an update on the latest developments in the area of rare adult solid rare cancers, with a background perspective on state-of-the-art and evidence based practice.

REGISTRATION
Registration for the course is required but free (link below).
Registration will be confirmed by e-mail.

OFFICIAL LANGUAGE

The official language is English. Translation is not provided.

CME ACCREDITATION CERTIFICATES

Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certficate that will be issued by email.

Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and 24 CME credits have been granted to this event. The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.

ESCO CREDITS

The Course enables ESCO students to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in the Course earns participants 22 ESCO credits.

Visit www.esco.org for information on how to join ESCO.

ORGANISING SECRETARIAT
Marina Fregonese - Event Organiser - mfregonese@eso.net
Dolores Knupfer - Event Organiser - dknupfer@eso.net
Mariachiara Deleo - e-ESO Assistant - mdeleo@eso.net
Francesca Marangoni - e-ESO Executive Manager - fmarangoni@eso.net

Follow us on Facebook, Twitter and Instagram: #e_ESO

Click HERE to view the course brochure

Instructions on how to use e-ESO to participate in this event

The course will remain available until JANUARY 2022.

Faculty list

Conflict of interest

How to enable pop-ups

Share on:

Moderator: Rolf A. Stahel

Introduction

Expert: Fedro Alessandro Peccatori

Expert: Rolf A. Stahel

Round table: The Rare Cancer Agenda 2030

Expert: Jean-Yves Blay

Expert: Paolo Giovanni Casali

Expert: Francesco De Lorenzo

Expert: Kathy Oliver

Expert: Annalisa Trama

Expert: Alexandru Eniu

Q&A and general discussion

Expert: Jean-Yves Blay

Expert: Paolo Giovanni Casali

Expert: Francesco De Lorenzo

Expert: Kathy Oliver

Expert: Rolf A. Stahel

Expert: Annalisa Trama

Expert: Alexandru Eniu

Moderator: Rolf A. Stahel

Q&A

Expert: Rolf A. Stahel

Expert: Marina Garassino

Clinical case discussion

Presenter: Giulia Galli

Moderator: Jean-Yves Blay

Q&A

Expert: Paolo Giovanni Casali

Expert: Jean-Yves Blay

Expert: Silvia Stacchiotti

Expert: Alessandro Gronchi

Expert: Sandra Strauss

Clinical case discussion

Expert: Anna Maria Frezza

Moderator: Lisa Licitra

Q&A

Expert: Cesare Piazza

Expert: Vincent Gregoire

Expert: Lisa Licitra

Expert: Laura Deborah Locati

Expert: Christian Simon

Expert: Loris De Cecco

Clinical case discussion

Expert: Carlo Resteghini

Moderator: Eric Baudin

Q&A

Expert: Nicola Fazio

Expert: Filippo De Braud

Expert: Eric Baudin

Clinical case discussion

Presenter: Giulia Arrivi

Moderator: Martin J. Van den Bent

Q&A

Expert: Riccardo Soffietti

Expert: Martin J. Van den Bent

Expert: Judith Balmana

Clinical case discussion

Presenter: Alessia Pellerino

Moderator: Lisa Licitra

Q&A

Expert: Alfredo Berruti

Expert: Jaume Capdevila

Expert: Lisa Licitra

Expert: Christelle de la Fouchardiere

Expert: Silvia Franceschi

Clinical case discussion

Presenter: Elena Colombo

Moderator: Filippo De Braud

Q&A

Expert: Robert Glynne-Jones

Expert: Marcello Deraco

Expert: Filippo De Braud

Expert: Lucjan Wyrwicz

Expert: Heinz-Josef Klumpen

Clinical case discussion

Expert: Monica Niger

Moderator: Andrea Necchi

Q&A

Expert: Jourik A. Gietema

Expert: Andrea Necchi

Survivorship

Moderator: Paolo Giovanni Casali

Moderator: Annalisa Trama

Q&A

Expert: Tit Albreht

Expert: Ruth Ladenstein

Moderator: Fedro Alessandro Peccatori

Q&A

Expert: Isabelle Ray-Coquard

Expert: Fedro Alessandro Peccatori

Expert: Michael Seckl

Expert: Domenica Lorusso

Clinical case discussion

Presenter: Stefanie Aust

Moderator: Sophie Piperno-Neumann

Q&A

Expert: Celeste Lebbé

Expert: Stefano Cavalieri

Expert: Martina Angi

Expert: Sophie Piperno-Neumann

Expert: Ellen Kapiteijn

Clinical case discussion

Presenter: Thais Tong

Closing remarks

Expert: Paolo Giovanni Casali

5th ESO-ESMO-RCE Clinical update on RARE ADULT SOLID CANCERS

Programme

The Joint Action on Rare Cancers: what next? (LECTURES) Materials available starting from 1 December 2020

The Rare Cancer Agenda 2030

The epidemiology of rare adult solid cancers

EURACAN: where we are?

The educational pathway on rare adult solid cancers

The Joint Action on Rare Cancers: what next? (ROUNDTABLE)

Update on RARE THORACIC CANCERS (LECTURES) Materials available starting from 1 December 2020

Mesothelioma

Thymic tumors

Update on RARE THORACIC CANCERS (Q&A and CASES)

Update on SARCOMAS (LECTURES) Materials available starting from 1 December 2020

Adult soft tissue sarcomas

GIST

Ewing sarcoma and osteosarcoma

Rare bone and soft tissue sarcomas

Improving the surgical margin in sarcomas

Update on SARCOMAS (Q&A and CASES)

Update on HEAD & NECK CANCERS (LECTURES) Materials available starting from 1 December 2020

Laryngeal & hypopharyngeal carcinoma

Oropharyngeal carcinoma

Nasopharyngeal carcinoma & sinonasal cancers

Salivary gland tumors

Oral cavity tumors

Advances in molecular biology

Update on HEAD & NECK CANCERS (Q&A and CASES)

Update on NEUROENDOCRINE TUMORS (LECTURES) Materials available starting from 1 December 2020

Thoracic NETs

Gastroenteropancreatic NETs

Update on NEUROENDOCRINE TUMORS (Q&A and CASES)

Update on CNS TUMORS (LECTURES) Materials available starting from 1 December 2020

Gliomas

Rare CNS tumors

Hereditary cancer risk syndromes

Update on CNS TUMORS (Q&A and CASES)

Update on ENDOCRINE GLAND TUMORS (LECTURES) Materials available starting from 1 December 2020

Adrenal cancer

Thyroid cancer

The epidemiological evidence of sovradiagnosis

Update on ENDOCRINE GLAND TUMORS (Q&A and CLINICAL CASES)

Update on DIGESTIVE RARE CANCERS (LECTURES) Materials available starting from 1 December 2020

Biliary tumors

Anal carcinoma

Peritoneal mesothelioma & pseudomyxoma

Update on DIGESTIVE RARE CANCERS (Q&A and CLINICAL CASES)

Update on RARE UROGENITAL CANCERS (LECTURES) Materials available starting from 1 December 2020

Testicular cancer

Penile cancer

Survivorship as a healthcare issue

High level views on survivorship. The Cancer Mission perspective. The commons of paediatric and adult cancer

Update on RARE UROGENITAL CANCERS (Q&A and CLINICAL CASES)

Update on RARE FEMALE GENITAL CANCERS (LECTURES) Materials available starting from 1 December 2020

Non-epithelial ovarian tumors

Trophoblastic tumors

Vulvar and vaginal cancers

Update on RARE FEMALE GENITAL CANCERS (Q&A and CASES)

Update on RARE SKIN TUMORS & UVEAL MELANOMA (LECTURES) Materials available starting from 1 December 2020

Merkel cell carcinoma

Cutaneous adnexal malignancies

Uveal melanoma

Update on RARE SKIN TUMORS & UVEAL MELANOMA (Q&A and CASES)